Premium
A PHASE 1 STUDY OF PRALATREXATE PLUS ROMIDEPSIN REVEALS MARKED ACTIVITY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) PERIPHERAL T‐CELL LYMPHOMA (PTCL)
Author(s) -
Amengual J.E.,
Lichtenstein R.,
Lue J.K.,
Sawas A.,
Deng C.,
Lichtenstein E.,
Khan K.,
Kim H.,
Atkins L.,
Turenne I.,
Rojas C.,
Chiuzan C.,
Cremers S.,
O'Connor O.A.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2437_75
Subject(s) - medicine , romidepsin , lymphoma , peripheral t cell lymphoma , gastroenterology , phases of clinical research , refractory (planetary science) , oncology , chemotherapy , t cell , immunology , immune system , biochemistry , chemistry , physics , histone deacetylase , astrobiology , gene , histone
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom